Litcius/Paper detail

Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies

Qinhuai Lai, Mengdan Wu, Ruixue Wang, Weirong Lai, Yiran Tao, Ying Lu, Yuxi Wang, Lin Yu, Ruirui Zhang, Yujia Peng, Xiaohua Jiang, Yuyin Fu, Xin Wang, Zhixiong Zhang, Cuiyu Guo, Wei Liao, Yiwen Zhang, Tai‐Ran Kang, Hao Chen, Yuqin Yao, Lantu Gou, Jinliang Yang

2020European Journal of Medicinal Chemistry31 citationsDOI

Topics & Concepts

ChemistryProdrugPharmacologyTrastuzumabCytotoxicityConjugateAntibodyOvarian cancerAntibody-drug conjugateLinkerDrugIC50In vitroCancerMonoclonal antibodyBreast cancerMedicineImmunologyBiochemistryInternal medicineMathematical analysisComputer scienceMathematicsOperating systemPeptidase Inhibition and AnalysisHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research
Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies | Litcius